A pre-treatment CT-based weighted radiomic approach combined with clinical characteristics to predict durable clinical benefits of immunotherapy in advanced lung cancer

被引：0
作者：
Zhenchen Zhu
Minjiang Chen
Ge Hu
Zhengsong Pan
Wei Han
Weixiong Tan
Zhen Zhou
Mengzhao Wang
Li Mao
Xiuli Li
Xin Sui
Lan Song
Yan Xu
Wei Song
Yizhou Yu
Zhengyu Jin
机构：
[1] Peking Union Medical College Hospital,Department of Radiology
[2] Chinese Academy of Medical Sciences and Peking Union Medical College,4+4 Medical Doctor Program
[3] Chinese Academy of Medical Sciences & Peking Union Medical College,Department of Respiratory and Critical Care Medicine
[4] Peking Union Medical College Hospital,Department of Epidemiology and Biostatistics, Institute of Basic Medicine Sciences
[5] Chinese Academy of Medical Sciences and Peking Union Medical College,Deepwise Artificial Intelligence (AI) Lab
[6] Chinese Academy of Medical Sciences and School of Basic Medicine,Department of Computer Science
[7] Peking Union Medical College,undefined
[8] Beijing Deepwise & League of PhD technology Co. Ltd,undefined
[9] The University of Hong Kong,undefined
来源：
European Radiology | 2023年 / 33卷
关键词：
Immunotherapy; Immune checkpoint inhibitors; Lung neoplasms; Machine learning; Progression-free survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3918 / 3930
页数：12
相关论文
共 65 条
  • [1] Rizvi NA(2015)Cancer immunology. mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer Science 348 124-128
  • [2] Hellmann MD(2018)The efficacy and safety of nivolumab, pembrolizumab, and atezolizumab in treatment of advanced non-small cell lung cancer Discov Med 26 155-166
  • [3] Snyder A(2016)Regulation of PD-L1: a novel role of pro-survival signalling in cancer Ann Oncol 27 409-416
  • [4] Chen R(2016)Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study Lancet Oncol 17 1497-1508
  • [5] Tao Y(2019)Nivolumab plus ipilimumab in advanced non-small-cell lung cancer N Engl J Med 381 2020-2031
  • [6] Xu X(2019)Novel clinical and radiomic predictors of rapid disease progression phenotypes among lung cancer patients treated with immunotherapy: An early report Lung Cancer 129 75-79
  • [7] Chen J(2021)A CT-based radiomics signature is associated with response to immune checkpoint inhibitors in advanced solid tumors Radiology 299 109-119
  • [8] Jiang CC(2019)Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers Ann Oncol 30 998-1004
  • [9] Jin L(2020)Survival-relevant high-risk subregion identification for glioblastoma patients: the MRI-based multiple instance learning approach Eur Radiol 30 5602-5610
  • [10] Zhang XD(2021)Data-efficient and weakly supervised computational pathology on whole-slide images Nat Biomed Eng 5 555-570
1234567